Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial
Thank you for registering! Take a moment to confirm your subscription to MarketBeat Daily Ratings so that you can access MarketBeat's tools, reports, and news. Please click the "Send Confirmation Email" button and we'll send you an email with confirmation instructions.

Ironwood Pharmaceuticals (IRWD) SEC Filings & 10K Form

$6.48
-0.16 (-2.41%)
(As of 05/17/2024 08:53 PM ET)

Recent Ironwood Pharmaceuticals SEC Filings

DateFilerForm TypeView
05/09/2024
3:46 PM
Ironwood Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2024
6:09 AM
Ironwood Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2024
3:26 PM
Ironwood Pharmaceuticals (Filer)
Form DEF 14A
04/25/2024
3:28 PM
Ironwood Pharmaceuticals (Filer)
Form DEFA14A
04/25/2024
3:31 PM
Ironwood Pharmaceuticals (Filer)
Form ARS
02/16/2024
6:01 AM
Ironwood Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/15/2024
6:04 AM
Ironwood Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Elon’s New Device is About to Shock the World (Ad)

Using this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.”

Click here to see the details because there’s a lot of money at stake.
02/14/2024
8:01 PM
Ironwood Pharmaceuticals (Issuer)
John Minardo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
7:50 PM
Ironwood Pharmaceuticals (Issuer)
Silver Ronald (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
7:53 PM
Ironwood Pharmaceuticals (Issuer)
Shetzline Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
7:35 PM
Ironwood Pharmaceuticals (Issuer)
MCCOURT Thomas A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
7:39 PM
Emany Sravan Kumar (Reporting)
Ironwood Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
7:42 PM
Davis Andrew (Reporting)
Ironwood Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2024
2:12 PM
Ironwood Pharmaceuticals (Subject)
LSV ASSET MANAGEMENT (Filed by)
Form SC 13G/A
01/25/2024
8:21 AM
Ironwood Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/22/2024
1:03 PM
BlackRock Inc. (Filed by)
Ironwood Pharmaceuticals (Subject)
Form SC 13G/A
01/19/2024
3:05 PM
Emany Sravan Kumar (Reporting)
Ironwood Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
3:05 PM
Ironwood Pharmaceuticals (Issuer)
John Minardo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
3:05 PM
Ironwood Pharmaceuticals (Issuer)
Shetzline Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
3:05 PM
Ironwood Pharmaceuticals (Issuer)
MCCOURT Thomas A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
9:16 AM
Ironwood Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
01/08/2024
5:05 AM
Ironwood Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/14/2023
3:26 PM
Ironwood Pharmaceuticals (Subject)
Kessler Marla L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/09/2023
6:07 AM
Ironwood Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/18/2023
4:07 PM
Emany Sravan Kumar (Reporting)
Ironwood Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2023
3:30 PM
Ironwood Pharmaceuticals (Filer)
Form 8-K/A
08/16/2023
3:20 PM
Ironwood Pharmaceuticals (Issuer)
John Minardo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2023
3:21 PM
Ironwood Pharmaceuticals (Issuer)
Silver Ronald (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2023
3:02 PM
Ironwood Pharmaceuticals (Subject)
John Minardo (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/08/2023
6:08 AM
Ironwood Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2023
4:36 PM
Ironwood Pharmaceuticals (Subject)
Rickard Jason (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/07/2023
3:21 PM
Ironwood Pharmaceuticals (Filed by)
VectivBio Holding AG (Subject)
Form SC 13D
07/05/2023
11:01 AM
Ironwood Pharmaceuticals (Subject)
WESTFIELD CAPITAL MANAGEMENT CO LP (Filed by)
Form SC 13G/A
06/29/2023
7:32 AM
Ironwood Pharmaceuticals (Filed by)
VectivBio Holding AG (Subject)
Form SC TO-T/A
06/26/2023
3:08 PM
Ironwood Pharmaceuticals (Filed by)
VectivBio Holding AG (Subject)
Form SC TO-T/A
06/22/2023
4:26 PM
Currie Mark G (Reporting)
Ironwood Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2023
4:26 PM
DENNER ALEXANDER J (Reporting)
Ironwood Pharmaceuticals (Issuer)
Sarissa Capital Management LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2023
4:27 PM
Dreyfus Andrew (Reporting)
Ironwood Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2023
4:28 PM
Duane Jon R (Reporting)
Ironwood Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2023
4:29 PM
Ironwood Pharmaceuticals (Issuer)
Kessler Marla L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2023
4:29 PM
Ironwood Pharmaceuticals (Issuer)
McHugh Julie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Shocking $16T Elon Musk Crypto Leak (Ad)

Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.

Click here now to get your copy.
06/22/2023
4:30 PM
Ironwood Pharmaceuticals (Issuer)
Moukheibir Catherine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2023
4:31 PM
Ironwood Pharmaceuticals (Issuer)
Shepard Jay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2023
3:08 PM
Ironwood Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2023
3:05 PM
DENNER ALEXANDER J (Reporting)
Ironwood Pharmaceuticals (Issuer)
Sarissa Capital Management LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2023
3:05 PM
Ironwood Pharmaceuticals (Issuer)
Moukheibir Catherine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2023
6:30 AM
Ironwood Pharmaceuticals (Filed by)
VectivBio Holding AG (Subject)
Form SC TO-T/A
06/16/2023
6:09 AM
Ironwood Pharmaceuticals (Filed by)
VectivBio Holding AG (Subject)
Form SC TO-T/A
06/07/2023
5:08 PM
Ironwood Pharmaceuticals (Subject)
Rickard Jason (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/01/2023
4:45 PM
Ironwood Pharmaceuticals (Issuer)
MCCOURT Thomas A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2023
5:46 AM
Ironwood Pharmaceuticals (Filed by)
VectivBio Holding AG (Subject)
Form SC TO-T
05/24/2023
3:05 PM
Ironwood Pharmaceuticals (Issuer)
MCCOURT Thomas A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2023
3:05 PM
Davis Andrew (Reporting)
Ironwood Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2023
3:05 PM
Ironwood Pharmaceuticals (Issuer)
Shetzline Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2023
4:26 PM
Ironwood Pharmaceuticals (Filed by)
VectivBio Holding AG (Subject)
Form SC TO-C
05/22/2023
3:25 PM
Ironwood Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/19/2023
4:39 PM
Ironwood Pharmaceuticals (Subject)
MCCOURT Thomas A (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/19/2023
4:25 PM
Davis Andrew (Reporting)
Ironwood Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:IRWD) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners